FDA issued a Warning Letter to Bristol Myers Squibb Holdings Pharma., Ltd. on 8/30/2010 as a result of this inspection.
483 Bristol-Myers Squibb Holdings Pharma Liability Company Mar 2010

483 Bristol-Myers Squibb Holdings Pharma Liability Company Mar 2010

Jose Melendez FDA$119.00 - Available Now

FDA investigators audited the Bristol-Myers Squibb Holdings Pharma Liability Company - Manati, PR, United States facility and issued inspectional observation (via FDA 483) on 31 Mar 2010.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Mar 2010
  • Location: Manati, United States
  • FEI: 2650089
Add To Cart